カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ミノキシジル&フィナステリド原薬のグローバル市場展望 2023年-2029年：経口式、注射式、その他

◆英語タイトル：Minoxidil and Finasteride API Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14433）

◆商品コード：MMG23DC14433
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のミノキシジル&フィナステリド原薬市場規模と予測を収録しています。・世界のミノキシジル&フィナステリド原薬市場：売上、2018年-2023年、2024年-2029年
・世界のミノキシジル&フィナステリド原薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のミノキシジル&フィナステリド原薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口式」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ミノキシジル&フィナステリド原薬のグローバル主要企業は、Dr. Reddy’s Laboratories Ltd、 Global Calcium Private Limited、 Global Pharma、 Samex Overseas、 Ralington Pharma、 Icrom SpA、 Beloor Bayir、 Flamma Group、 SynZeal Research Pvt、 Curia Company、 Tiefenbacher API + Ingredients、 Taj Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ミノキシジル&フィナステリド原薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のミノキシジル&フィナステリド原薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のミノキシジル&フィナステリド原薬市場：タイプ別市場シェア、2022年
・経口式、注射式、その他

世界のミノキシジル&フィナステリド原薬市場：用途別、2018年-2023年、2024年-2029年
世界のミノキシジル&フィナステリド原薬市場：用途別市場シェア、2022年
・診療所、病院、その他

世界のミノキシジル&フィナステリド原薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のミノキシジル&フィナステリド原薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるミノキシジル&フィナステリド原薬のグローバル売上、2018年-2023年
・主要企業におけるミノキシジル&フィナステリド原薬のグローバル売上シェア、2022年
・主要企業におけるミノキシジル&フィナステリド原薬のグローバル販売量、2018年-2023年
・主要企業におけるミノキシジル&フィナステリド原薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Dr. Reddy’s Laboratories Ltd、 Global Calcium Private Limited、 Global Pharma、 Samex Overseas、 Ralington Pharma、 Icrom SpA、 Beloor Bayir、 Flamma Group、 SynZeal Research Pvt、 Curia Company、 Tiefenbacher API + Ingredients、 Taj Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
ミノキシジル&フィナステリド原薬市場の定義
市場セグメント
世界のミノキシジル&フィナステリド原薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のミノキシジル&フィナステリド原薬市場規模
世界のミノキシジル&フィナステリド原薬市場規模：2022年 VS 2029年
世界のミノキシジル&フィナステリド原薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのミノキシジル&フィナステリド原薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のミノキシジル&フィナステリド原薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口式、注射式、その他
ミノキシジル&フィナステリド原薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：診療所、病院、その他
ミノキシジル&フィナステリド原薬の用途別グローバル売上・予測

・地域別市場分析
地域別ミノキシジル&フィナステリド原薬市場規模 2022年と2029年
地域別ミノキシジル&フィナステリド原薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Dr. Reddy’s Laboratories Ltd、 Global Calcium Private Limited、 Global Pharma、 Samex Overseas、 Ralington Pharma、 Icrom SpA、 Beloor Bayir、 Flamma Group、 SynZeal Research Pvt、 Curia Company、 Tiefenbacher API + Ingredients、 Taj Pharmaceuticals
...

This research report provides a comprehensive analysis of the Minoxidil and Finasteride API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Minoxidil and Finasteride API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Minoxidil and Finasteride API, challenges faced by the industry, and potential opportunities for market players.
The global Minoxidil and Finasteride API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Minoxidil and Finasteride API market presents opportunities for various stakeholders, including Clinic, Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Minoxidil and Finasteride API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Minoxidil and Finasteride API market was valued at US$ 141.5 million in 2022 and is projected to reach US$ 216.6 million by 2029, at a CAGR of 6.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Minoxidil and Finasteride API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Minoxidil and Finasteride API market.
Market Overview: The report provides a comprehensive overview of the Minoxidil and Finasteride API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral, Injectable), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Minoxidil and Finasteride API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Minoxidil and Finasteride API market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Minoxidil and Finasteride API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Minoxidil and Finasteride API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Minoxidil and Finasteride API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Minoxidil and Finasteride API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Minoxidil and Finasteride API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Minoxidil and Finasteride API market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Minoxidil and Finasteride API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Oral
Injectable
Others
Market segment by Application
Clinic
Hospital
Others
Global Minoxidil and Finasteride API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Dr. Reddy’s Laboratories Ltd
Global Calcium Private Limited
Global Pharma
Samex Overseas
Ralington Pharma
Icrom SpA
Beloor Bayir
Flamma Group
SynZeal Research Pvt
Curia Company
Tiefenbacher API + Ingredients
Taj Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Minoxidil and Finasteride API, market overview.
Chapter 2: Global Minoxidil and Finasteride API market size in revenue and volume.
Chapter 3: Detailed analysis of Minoxidil and Finasteride API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Minoxidil and Finasteride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Minoxidil and Finasteride API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Minoxidil and Finasteride API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Minoxidil and Finasteride API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Minoxidil and Finasteride API Overall Market Size
2.1 Global Minoxidil and Finasteride API Market Size: 2022 VS 2029
2.2 Global Minoxidil and Finasteride API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Minoxidil and Finasteride API Sales: 2018-2029
3 Company Landscape
3.1 Top Minoxidil and Finasteride API Players in Global Market
3.2 Top Global Minoxidil and Finasteride API Companies Ranked by Revenue
3.3 Global Minoxidil and Finasteride API Revenue by Companies
3.4 Global Minoxidil and Finasteride API Sales by Companies
3.5 Global Minoxidil and Finasteride API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Minoxidil and Finasteride API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Minoxidil and Finasteride API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Minoxidil and Finasteride API Players in Global Market
3.8.1 List of Global Tier 1 Minoxidil and Finasteride API Companies
3.8.2 List of Global Tier 2 and Tier 3 Minoxidil and Finasteride API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Minoxidil and Finasteride API Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injectable
4.1.4 Others
4.2 By Type – Global Minoxidil and Finasteride API Revenue & Forecasts
4.2.1 By Type – Global Minoxidil and Finasteride API Revenue, 2018-2023
4.2.2 By Type – Global Minoxidil and Finasteride API Revenue, 2024-2029
4.2.3 By Type – Global Minoxidil and Finasteride API Revenue Market Share, 2018-2029
4.3 By Type – Global Minoxidil and Finasteride API Sales & Forecasts
4.3.1 By Type – Global Minoxidil and Finasteride API Sales, 2018-2023
4.3.2 By Type – Global Minoxidil and Finasteride API Sales, 2024-2029
4.3.3 By Type – Global Minoxidil and Finasteride API Sales Market Share, 2018-2029
4.4 By Type – Global Minoxidil and Finasteride API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Minoxidil and Finasteride API Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application – Global Minoxidil and Finasteride API Revenue & Forecasts
5.2.1 By Application – Global Minoxidil and Finasteride API Revenue, 2018-2023
5.2.2 By Application – Global Minoxidil and Finasteride API Revenue, 2024-2029
5.2.3 By Application – Global Minoxidil and Finasteride API Revenue Market Share, 2018-2029
5.3 By Application – Global Minoxidil and Finasteride API Sales & Forecasts
5.3.1 By Application – Global Minoxidil and Finasteride API Sales, 2018-2023
5.3.2 By Application – Global Minoxidil and Finasteride API Sales, 2024-2029
5.3.3 By Application – Global Minoxidil and Finasteride API Sales Market Share, 2018-2029
5.4 By Application – Global Minoxidil and Finasteride API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Minoxidil and Finasteride API Market Size, 2022 & 2029
6.2 By Region – Global Minoxidil and Finasteride API Revenue & Forecasts
6.2.1 By Region – Global Minoxidil and Finasteride API Revenue, 2018-2023
6.2.2 By Region – Global Minoxidil and Finasteride API Revenue, 2024-2029
6.2.3 By Region – Global Minoxidil and Finasteride API Revenue Market Share, 2018-2029
6.3 By Region – Global Minoxidil and Finasteride API Sales & Forecasts
6.3.1 By Region – Global Minoxidil and Finasteride API Sales, 2018-2023
6.3.2 By Region – Global Minoxidil and Finasteride API Sales, 2024-2029
6.3.3 By Region – Global Minoxidil and Finasteride API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Minoxidil and Finasteride API Revenue, 2018-2029
6.4.2 By Country – North America Minoxidil and Finasteride API Sales, 2018-2029
6.4.3 US Minoxidil and Finasteride API Market Size, 2018-2029
6.4.4 Canada Minoxidil and Finasteride API Market Size, 2018-2029
6.4.5 Mexico Minoxidil and Finasteride API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Minoxidil and Finasteride API Revenue, 2018-2029
6.5.2 By Country – Europe Minoxidil and Finasteride API Sales, 2018-2029
6.5.3 Germany Minoxidil and Finasteride API Market Size, 2018-2029
6.5.4 France Minoxidil and Finasteride API Market Size, 2018-2029
6.5.5 U.K. Minoxidil and Finasteride API Market Size, 2018-2029
6.5.6 Italy Minoxidil and Finasteride API Market Size, 2018-2029
6.5.7 Russia Minoxidil and Finasteride API Market Size, 2018-2029
6.5.8 Nordic Countries Minoxidil and Finasteride API Market Size, 2018-2029
6.5.9 Benelux Minoxidil and Finasteride API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Minoxidil and Finasteride API Revenue, 2018-2029
6.6.2 By Region – Asia Minoxidil and Finasteride API Sales, 2018-2029
6.6.3 China Minoxidil and Finasteride API Market Size, 2018-2029
6.6.4 Japan Minoxidil and Finasteride API Market Size, 2018-2029
6.6.5 South Korea Minoxidil and Finasteride API Market Size, 2018-2029
6.6.6 Southeast Asia Minoxidil and Finasteride API Market Size, 2018-2029
6.6.7 India Minoxidil and Finasteride API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Minoxidil and Finasteride API Revenue, 2018-2029
6.7.2 By Country – South America Minoxidil and Finasteride API Sales, 2018-2029
6.7.3 Brazil Minoxidil and Finasteride API Market Size, 2018-2029
6.7.4 Argentina Minoxidil and Finasteride API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Minoxidil and Finasteride API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Minoxidil and Finasteride API Sales, 2018-2029
6.8.3 Turkey Minoxidil and Finasteride API Market Size, 2018-2029
6.8.4 Israel Minoxidil and Finasteride API Market Size, 2018-2029
6.8.5 Saudi Arabia Minoxidil and Finasteride API Market Size, 2018-2029
6.8.6 UAE Minoxidil and Finasteride API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Dr. Reddy’s Laboratories Ltd
7.1.1 Dr. Reddy’s Laboratories Ltd Company Summary
7.1.2 Dr. Reddy’s Laboratories Ltd Business Overview
7.1.3 Dr. Reddy’s Laboratories Ltd Minoxidil and Finasteride API Major Product Offerings
7.1.4 Dr. Reddy’s Laboratories Ltd Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.1.5 Dr. Reddy’s Laboratories Ltd Key News & Latest Developments
7.2 Global Calcium Private Limited
7.2.1 Global Calcium Private Limited Company Summary
7.2.2 Global Calcium Private Limited Business Overview
7.2.3 Global Calcium Private Limited Minoxidil and Finasteride API Major Product Offerings
7.2.4 Global Calcium Private Limited Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.2.5 Global Calcium Private Limited Key News & Latest Developments
7.3 Global Pharma
7.3.1 Global Pharma Company Summary
7.3.2 Global Pharma Business Overview
7.3.3 Global Pharma Minoxidil and Finasteride API Major Product Offerings
7.3.4 Global Pharma Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.3.5 Global Pharma Key News & Latest Developments
7.4 Samex Overseas
7.4.1 Samex Overseas Company Summary
7.4.2 Samex Overseas Business Overview
7.4.3 Samex Overseas Minoxidil and Finasteride API Major Product Offerings
7.4.4 Samex Overseas Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.4.5 Samex Overseas Key News & Latest Developments
7.5 Ralington Pharma
7.5.1 Ralington Pharma Company Summary
7.5.2 Ralington Pharma Business Overview
7.5.3 Ralington Pharma Minoxidil and Finasteride API Major Product Offerings
7.5.4 Ralington Pharma Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.5.5 Ralington Pharma Key News & Latest Developments
7.6 Icrom SpA
7.6.1 Icrom SpA Company Summary
7.6.2 Icrom SpA Business Overview
7.6.3 Icrom SpA Minoxidil and Finasteride API Major Product Offerings
7.6.4 Icrom SpA Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.6.5 Icrom SpA Key News & Latest Developments
7.7 Beloor Bayir
7.7.1 Beloor Bayir Company Summary
7.7.2 Beloor Bayir Business Overview
7.7.3 Beloor Bayir Minoxidil and Finasteride API Major Product Offerings
7.7.4 Beloor Bayir Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.7.5 Beloor Bayir Key News & Latest Developments
7.8 Flamma Group
7.8.1 Flamma Group Company Summary
7.8.2 Flamma Group Business Overview
7.8.3 Flamma Group Minoxidil and Finasteride API Major Product Offerings
7.8.4 Flamma Group Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.8.5 Flamma Group Key News & Latest Developments
7.9 SynZeal Research Pvt
7.9.1 SynZeal Research Pvt Company Summary
7.9.2 SynZeal Research Pvt Business Overview
7.9.3 SynZeal Research Pvt Minoxidil and Finasteride API Major Product Offerings
7.9.4 SynZeal Research Pvt Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.9.5 SynZeal Research Pvt Key News & Latest Developments
7.10 Curia Company
7.10.1 Curia Company Company Summary
7.10.2 Curia Company Business Overview
7.10.3 Curia Company Minoxidil and Finasteride API Major Product Offerings
7.10.4 Curia Company Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.10.5 Curia Company Key News & Latest Developments
7.11 Tiefenbacher API + Ingredients
7.11.1 Tiefenbacher API + Ingredients Company Summary
7.11.2 Tiefenbacher API + Ingredients Business Overview
7.11.3 Tiefenbacher API + Ingredients Minoxidil and Finasteride API Major Product Offerings
7.11.4 Tiefenbacher API + Ingredients Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.11.5 Tiefenbacher API + Ingredients Key News & Latest Developments
7.12 Taj Pharmaceuticals
7.12.1 Taj Pharmaceuticals Company Summary
7.12.2 Taj Pharmaceuticals Business Overview
7.12.3 Taj Pharmaceuticals Minoxidil and Finasteride API Major Product Offerings
7.12.4 Taj Pharmaceuticals Minoxidil and Finasteride API Sales and Revenue in Global (2018-2023)
7.12.5 Taj Pharmaceuticals Key News & Latest Developments
8 Global Minoxidil and Finasteride API Production Capacity, Analysis
8.1 Global Minoxidil and Finasteride API Production Capacity, 2018-2029
8.2 Minoxidil and Finasteride API Production Capacity of Key Manufacturers in Global Market
8.3 Global Minoxidil and Finasteride API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Minoxidil and Finasteride API Supply Chain Analysis
10.1 Minoxidil and Finasteride API Industry Value Chain
10.2 Minoxidil and Finasteride API Upstream Market
10.3 Minoxidil and Finasteride API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Minoxidil and Finasteride API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Minoxidil and Finasteride API in Global Market
Table 2. Top Minoxidil and Finasteride API Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Minoxidil and Finasteride API Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Minoxidil and Finasteride API Revenue Share by Companies, 2018-2023
Table 5. Global Minoxidil and Finasteride API Sales by Companies, (K Units), 2018-2023
Table 6. Global Minoxidil and Finasteride API Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Minoxidil and Finasteride API Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Minoxidil and Finasteride API Product Type
Table 9. List of Global Tier 1 Minoxidil and Finasteride API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Minoxidil and Finasteride API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Minoxidil and Finasteride API Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Minoxidil and Finasteride API Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Minoxidil and Finasteride API Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Minoxidil and Finasteride API Sales (K Units), 2018-2023
Table 15. By Type - Global Minoxidil and Finasteride API Sales (K Units), 2024-2029
Table 16. By Application – Global Minoxidil and Finasteride API Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Minoxidil and Finasteride API Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Minoxidil and Finasteride API Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Minoxidil and Finasteride API Sales (K Units), 2018-2023
Table 20. By Application - Global Minoxidil and Finasteride API Sales (K Units), 2024-2029
Table 21. By Region – Global Minoxidil and Finasteride API Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Minoxidil and Finasteride API Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Minoxidil and Finasteride API Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Minoxidil and Finasteride API Sales (K Units), 2018-2023
Table 25. By Region - Global Minoxidil and Finasteride API Sales (K Units), 2024-2029
Table 26. By Country - North America Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Minoxidil and Finasteride API Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Minoxidil and Finasteride API Sales, (K Units), 2018-2023
Table 29. By Country - North America Minoxidil and Finasteride API Sales, (K Units), 2024-2029
Table 30. By Country - Europe Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Minoxidil and Finasteride API Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Minoxidil and Finasteride API Sales, (K Units), 2018-2023
Table 33. By Country - Europe Minoxidil and Finasteride API Sales, (K Units), 2024-2029
Table 34. By Region - Asia Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Minoxidil and Finasteride API Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Minoxidil and Finasteride API Sales, (K Units), 2018-2023
Table 37. By Region - Asia Minoxidil and Finasteride API Sales, (K Units), 2024-2029
Table 38. By Country - South America Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Minoxidil and Finasteride API Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Minoxidil and Finasteride API Sales, (K Units), 2018-2023
Table 41. By Country - South America Minoxidil and Finasteride API Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Minoxidil and Finasteride API Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Minoxidil and Finasteride API Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Minoxidil and Finasteride API Sales, (K Units), 2024-2029
Table 46. Dr. Reddy’s Laboratories Ltd Company Summary
Table 47. Dr. Reddy’s Laboratories Ltd Minoxidil and Finasteride API Product Offerings
Table 48. Dr. Reddy’s Laboratories Ltd Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Dr. Reddy’s Laboratories Ltd Key News & Latest Developments
Table 50. Global Calcium Private Limited Company Summary
Table 51. Global Calcium Private Limited Minoxidil and Finasteride API Product Offerings
Table 52. Global Calcium Private Limited Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Global Calcium Private Limited Key News & Latest Developments
Table 54. Global Pharma Company Summary
Table 55. Global Pharma Minoxidil and Finasteride API Product Offerings
Table 56. Global Pharma Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Global Pharma Key News & Latest Developments
Table 58. Samex Overseas Company Summary
Table 59. Samex Overseas Minoxidil and Finasteride API Product Offerings
Table 60. Samex Overseas Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Samex Overseas Key News & Latest Developments
Table 62. Ralington Pharma Company Summary
Table 63. Ralington Pharma Minoxidil and Finasteride API Product Offerings
Table 64. Ralington Pharma Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Ralington Pharma Key News & Latest Developments
Table 66. Icrom SpA Company Summary
Table 67. Icrom SpA Minoxidil and Finasteride API Product Offerings
Table 68. Icrom SpA Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Icrom SpA Key News & Latest Developments
Table 70. Beloor Bayir Company Summary
Table 71. Beloor Bayir Minoxidil and Finasteride API Product Offerings
Table 72. Beloor Bayir Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Beloor Bayir Key News & Latest Developments
Table 74. Flamma Group Company Summary
Table 75. Flamma Group Minoxidil and Finasteride API Product Offerings
Table 76. Flamma Group Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Flamma Group Key News & Latest Developments
Table 78. SynZeal Research Pvt Company Summary
Table 79. SynZeal Research Pvt Minoxidil and Finasteride API Product Offerings
Table 80. SynZeal Research Pvt Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. SynZeal Research Pvt Key News & Latest Developments
Table 82. Curia Company Company Summary
Table 83. Curia Company Minoxidil and Finasteride API Product Offerings
Table 84. Curia Company Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Curia Company Key News & Latest Developments
Table 86. Tiefenbacher API + Ingredients Company Summary
Table 87. Tiefenbacher API + Ingredients Minoxidil and Finasteride API Product Offerings
Table 88. Tiefenbacher API + Ingredients Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Tiefenbacher API + Ingredients Key News & Latest Developments
Table 90. Taj Pharmaceuticals Company Summary
Table 91. Taj Pharmaceuticals Minoxidil and Finasteride API Product Offerings
Table 92. Taj Pharmaceuticals Minoxidil and Finasteride API Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Taj Pharmaceuticals Key News & Latest Developments
Table 94. Minoxidil and Finasteride API Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Minoxidil and Finasteride API Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Minoxidil and Finasteride API Production by Region, 2018-2023 (K Units)
Table 97. Global Minoxidil and Finasteride API Production by Region, 2024-2029 (K Units)
Table 98. Minoxidil and Finasteride API Market Opportunities & Trends in Global Market
Table 99. Minoxidil and Finasteride API Market Drivers in Global Market
Table 100. Minoxidil and Finasteride API Market Restraints in Global Market
Table 101. Minoxidil and Finasteride API Raw Materials
Table 102. Minoxidil and Finasteride API Raw Materials Suppliers in Global Market
Table 103. Typical Minoxidil and Finasteride API Downstream
Table 104. Minoxidil and Finasteride API Downstream Clients in Global Market
Table 105. Minoxidil and Finasteride API Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Minoxidil and Finasteride API Segment by Type in 2022
Figure 2. Minoxidil and Finasteride API Segment by Application in 2022
Figure 3. Global Minoxidil and Finasteride API Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Minoxidil and Finasteride API Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Minoxidil and Finasteride API Revenue, 2018-2029 (US$, Mn)
Figure 7. Minoxidil and Finasteride API Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Minoxidil and Finasteride API Revenue in 2022
Figure 9. By Type - Global Minoxidil and Finasteride API Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 11. By Type - Global Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 12. By Type - Global Minoxidil and Finasteride API Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Minoxidil and Finasteride API Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 15. By Application - Global Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 16. By Application - Global Minoxidil and Finasteride API Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Minoxidil and Finasteride API Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Minoxidil and Finasteride API Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 20. By Region - Global Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 21. By Country - North America Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 22. By Country - North America Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 23. US Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 28. Germany Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 29. France Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 37. China Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 41. India Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 43. By Country - South America Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 44. Brazil Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Minoxidil and Finasteride API Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Minoxidil and Finasteride API Sales Market Share, 2018-2029
Figure 48. Turkey Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Minoxidil and Finasteride API Revenue, (US$, Mn), 2018-2029
Figure 52. Global Minoxidil and Finasteride API Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Minoxidil and Finasteride API by Region, 2022 VS 2029
Figure 54. Minoxidil and Finasteride API Industry Value Chain
Figure 55. Marketing Channels

※参考情報

ミノキシジルとフィナステリドは、薄毛症や脱毛症の治療に用いられる薬剤であり、それぞれ異なるメカニズムと特性を持っています。これらの原薬は、一般的に医薬品としての用途に限られず、さまざまな関連技術や研究の対象となっています。以下では、それぞれの概念について詳しく説明いたします。

ミノキシジルは、1970年代に高血圧の治療薬として初めて使用されました。これが後に、薄毛治療の外用薬としての利用に発展したのです。ミノキシジルは血管拡張作用を持つことで知られていますが、毛髪に関しては特に血行促進効果が重要です。この薬剤は毛根の血液供給を改善し、毛髪の成長を促進することによって、脱毛症の症状を軽減します。

ミノキシジルには、主に外用液とローションの形態が存在します。これらは通常、1%から5%の濃度で提供されており、使用者の年齢や薄毛の進行度に応じて選択されます。外用薬としてのミノキシジルは、特に男性型脱毛症や女性型脱毛症の治療に有効であることが多く、一定の割合で毛髪の再生が見込まれます。また、ミノキシジルの副作用としては、頭皮のかゆみや、まれに心拍数の上昇などが報告されていますが、一般的には高い安全性が評価されています。

一方、フィナステリドは、酵素の5α-還元酵素を阻害する作用を持つことから、特に男性型脱毛症に対する効果が期待されます。フィナステリドのメカニズムは、テストステロンがジヒドロテストステロン（DHT）に変換される過程を防ぐことによって、毛髪の脱落を遅らせることにあります。DHTは男性型脱毛症の主要因とされていますので、フィナステリドを使用することで脱毛の進行を食い止めることができるのです。

フィナステリドは、通常、1mgの錠剤形式で提供されます。この薬剤は、特に30歳以上の男性に対して効果が高いとされています。フィナステリドの主な副作用には、性機能障害（勃起不全や性欲減退など）が含まれますが、多くの使用者にとっては副作用が軽度であることが多く、効果の方が大きな利点とされています。

ミノキシジルとフィナステリドは、単独でも効果を発揮しますが、併用することにより相乗的な効果が期待されることが多いです。たとえば、ミノキシジルが毛髪の成長を促進し、フィナステリドがその成長を支える環境を作ることで、より高い効果が得られる可能性があります。このため、薄毛治療においては、医師の指導のもとでの併用が推奨される場合もあります。

関連技術としては、治療法の進化が挙げられます。近年では、ミノキシジルやフィナステリドの効果をさらに高めるための新しい治療法が開発されています。たとえば、低出力レーザー治療（LLLT）は、光を用いて毛髪の成長を促進する非侵襲的な方法として注目されています。また、再生医療や幹細胞技術を利用した治療法も研究されており、今後の進展が期待されています。

さらに、生活習慣や栄養状態といった、外的要因も薄毛に影響を与えるため、栄養補助食品やスカルプケア製品の使用も推奨されることがあります。これにより、体内からのアプローチのみならず、外部からのアプローチを組み合わせたトータルケアが重要視されています。

ミノキシジルとフィナステリドの使用にあたっては、医師との相談が不可欠です。個々の状態や反応を考慮した使用方法が求められるため、適切な診療を受けることが重要です。また、効果が出るまでには数ヶ月かかることが一般的であり、その間に根気よく治療を続ける姿勢も必要です。

薄毛症や脱毛症は、多くの人々にとって精神的な負担となりますが、ミノキシジルやフィナステリドをはじめとする治療法の進化により、改善される可能性が近年高まっています。これらの治療がすべての人に適しているわけではありませんが、正しい知識を持ち、適切な医療の選択を行うことで、多くの人々が自信を取り戻す手助けを受けることができるといえるでしょう。今後もさらなる研究と技術革新が期待され、薄毛治療に関する選択肢がより広がっていくことが望まれます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ミノキシジル&フィナステリド原薬のグローバル市場展望 2023年-2029年：経口式、注射式、その他(Minoxidil and Finasteride API Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ミノキシジル&フィナステリド原薬のグローバル市場展望 2023年-2029年：経口式、注射式、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp